Brief: Atara Biotherapeutics Q2 EPS USD -3.1
12/08/2024 22:00
Aug 12 (Reuters) - Atara Biotherapeutics Q2 operating income USD -18.231 million. * Q2 revenue USD 28.64 million vs. IBES estimate USD 40 million * Q2 net income USD -19.049 million
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM